Erratum: LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of pancreatic cancer: Erratum (Theranostics (2020) 10:22 (10274-10289) DOI: 10.7150/thno.47001)

Biao Zheng; Jianhua Qu; Kenoki Ohuchida; Haimin Feng; Stephen Jun Fei Chong; Zilong Yan; Yicui Piao; Peng Liu; Nan Sheng; Daiki Eguchi; Takao Ohtsuka; Kazuhiro Mizumoto; Zhong Liu; Shazib Pervaiz; Peng Gong; Masafumi Nakamura

doi:10.7150/thno.68023

Erratum: LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of pancreatic cancer: Erratum (Theranostics (2020) 10:22 (10274-10289) DOI: 10.7150/thno.47001)

Biao Zheng, Jianhua Qu, Kenoki Ohuchida, Haimin Feng, Stephen Jun Fei Chong, Zilong Yan, Yicui Piao, Peng Liu, Nan Sheng, Daiki Eguchi, Takao Ohtsuka, Kazuhiro Mizumoto, Zhong Liu, Shazib Pervaiz, Peng Gong, Masafumi Nakamura

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In the original Figure 6C of our article [1], we mistakenly repeatedly used the LAMA4 shRNA-1 knockdown figure (Figure 6C, bottom middle) as the LAMA4 shRNA-2 knockdown figure (Figure 6C, bottom right) in the cell migration assay of CAFs. The Figure 6C should be corrected as follows. The figure corrected in this erratum does not influence any original conclusions in our study. We apologize for any inconvenience or misunderstanding that this error may have caused.

Original language	English
Pages (from-to)	10171-10172
Number of pages	2
Journal	Theranostics
Volume	11
Issue number	20
DOIs	https://doi.org/10.7150/thno.68023
Publication status	Published - 2021

All Science Journal Classification (ASJC) codes

Medicine (miscellaneous)
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.7150/thno.68023

Cite this

Zheng, B., Qu, J., Ohuchida, K., Feng, H., Chong, S. J. F., Yan, Z., Piao, Y., Liu, P., Sheng, N., Eguchi, D., Ohtsuka, T., Mizumoto, K., Liu, Z., Pervaiz, S., Gong, P., & Nakamura, M. (2021). Erratum: LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of pancreatic cancer: Erratum (Theranostics (2020) 10:22 (10274-10289) DOI: 10.7150/thno.47001). Theranostics, 11(20), 10171-10172. https://doi.org/10.7150/thno.68023

Erratum : LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of pancreatic cancer: Erratum (Theranostics (2020) 10:22 (10274-10289) DOI: 10.7150/thno.47001). / Zheng, Biao; Qu, Jianhua; Ohuchida, Kenoki; Feng, Haimin; Chong, Stephen Jun Fei; Yan, Zilong; Piao, Yicui; Liu, Peng; Sheng, Nan; Eguchi, Daiki; Ohtsuka, Takao; Mizumoto, Kazuhiro; Liu, Zhong; Pervaiz, Shazib; Gong, Peng; Nakamura, Masafumi.

In: Theranostics, Vol. 11, No. 20, 2021, p. 10171-10172.

Research output: Contribution to journal › Comment/debate › peer-review

Zheng, B, Qu, J, Ohuchida, K, Feng, H, Chong, SJF, Yan, Z, Piao, Y, Liu, P, Sheng, N, Eguchi, D, Ohtsuka, T, Mizumoto, K, Liu, Z, Pervaiz, S, Gong, P & Nakamura, M 2021, 'Erratum: LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of pancreatic cancer: Erratum (Theranostics (2020) 10:22 (10274-10289) DOI: 10.7150/thno.47001)', Theranostics, vol. 11, no. 20, pp. 10171-10172. https://doi.org/10.7150/thno.68023

Zheng, Biao ; Qu, Jianhua ; Ohuchida, Kenoki ; Feng, Haimin ; Chong, Stephen Jun Fei ; Yan, Zilong ; Piao, Yicui ; Liu, Peng ; Sheng, Nan ; Eguchi, Daiki ; Ohtsuka, Takao ; Mizumoto, Kazuhiro ; Liu, Zhong ; Pervaiz, Shazib ; Gong, Peng ; Nakamura, Masafumi. / Erratum : LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of pancreatic cancer: Erratum (Theranostics (2020) 10:22 (10274-10289) DOI: 10.7150/thno.47001). In: Theranostics. 2021 ; Vol. 11, No. 20. pp. 10171-10172.

@article{8bcacde8445e426e83cd99b2150b919b,

title = "Erratum: LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of pancreatic cancer: Erratum (Theranostics (2020) 10:22 (10274-10289) DOI: 10.7150/thno.47001)",

abstract = "In the original Figure 6C of our article [1], we mistakenly repeatedly used the LAMA4 shRNA-1 knockdown figure (Figure 6C, bottom middle) as the LAMA4 shRNA-2 knockdown figure (Figure 6C, bottom right) in the cell migration assay of CAFs. The Figure 6C should be corrected as follows. The figure corrected in this erratum does not influence any original conclusions in our study. We apologize for any inconvenience or misunderstanding that this error may have caused. ",

author = "Biao Zheng and Jianhua Qu and Kenoki Ohuchida and Haimin Feng and Chong, {Stephen Jun Fei} and Zilong Yan and Yicui Piao and Peng Liu and Nan Sheng and Daiki Eguchi and Takao Ohtsuka and Kazuhiro Mizumoto and Zhong Liu and Shazib Pervaiz and Peng Gong and Masafumi Nakamura",

note = "Publisher Copyright: {\textcopyright} The author(s).",

year = "2021",

doi = "10.7150/thno.68023",

language = "English",

volume = "11",

pages = "10171--10172",

journal = "Theranostics",

issn = "1838-7640",

publisher = "Ivyspring International Publisher",

number = "20",

}

TY - JOUR

T1 - Erratum

T2 - LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of pancreatic cancer: Erratum (Theranostics (2020) 10:22 (10274-10289) DOI: 10.7150/thno.47001)

AU - Zheng, Biao

AU - Qu, Jianhua

AU - Ohuchida, Kenoki

AU - Feng, Haimin

AU - Chong, Stephen Jun Fei

AU - Yan, Zilong

AU - Piao, Yicui

AU - Liu, Peng

AU - Sheng, Nan

AU - Eguchi, Daiki

AU - Ohtsuka, Takao

AU - Mizumoto, Kazuhiro

AU - Liu, Zhong

AU - Pervaiz, Shazib

AU - Gong, Peng

AU - Nakamura, Masafumi

PY - 2021

Y1 - 2021

N2 - In the original Figure 6C of our article [1], we mistakenly repeatedly used the LAMA4 shRNA-1 knockdown figure (Figure 6C, bottom middle) as the LAMA4 shRNA-2 knockdown figure (Figure 6C, bottom right) in the cell migration assay of CAFs. The Figure 6C should be corrected as follows. The figure corrected in this erratum does not influence any original conclusions in our study. We apologize for any inconvenience or misunderstanding that this error may have caused.

AB - In the original Figure 6C of our article [1], we mistakenly repeatedly used the LAMA4 shRNA-1 knockdown figure (Figure 6C, bottom middle) as the LAMA4 shRNA-2 knockdown figure (Figure 6C, bottom right) in the cell migration assay of CAFs. The Figure 6C should be corrected as follows. The figure corrected in this erratum does not influence any original conclusions in our study. We apologize for any inconvenience or misunderstanding that this error may have caused.

UR - http://www.scopus.com/inward/record.url?scp=85119994855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85119994855&partnerID=8YFLogxK

U2 - 10.7150/thno.68023

DO - 10.7150/thno.68023

M3 - Comment/debate

AN - SCOPUS:85119994855

VL - 11

SP - 10171

EP - 10172

JO - Theranostics

JF - Theranostics

SN - 1838-7640

IS - 20

ER -

Erratum: LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of pancreatic cancer: Erratum (Theranostics (2020) 10:22 (10274-10289) DOI: 10.7150/thno.47001)

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this